Literature DB >> 19748363

Checkpoint signaling from a single DNA interstrand crosslink.

Merav Ben-Yehoyada1, Lily C Wang, Ivan D Kozekov, Carmelo J Rizzo, Max E Gottesman, Jean Gautier.   

Abstract

DNA interstrand crosslinks (ICLs) are the most toxic lesions induced by chemotherapeutic agents such as mitomycin C and cisplatin. By covalently linking both DNA strands, ICLs prevent DNA melting, transcription, and replication. Studies on ICL signaling and repair have been limited, because these drugs generate additional DNA lesions that trigger checkpoint signaling. Here, we monitor sensing, signaling from, and repairing of a single site-specific ICL in cell-free extract derived from Xenopus eggs and in mammalian cells. Notably, we demonstrate that ICLs trigger a checkpoint response independently of origin-initiated DNA replication and uncoupling of DNA polymerase and DNA helicase. The Fanconi anemia pathway acts upstream of RPA-ATR-Chk1 to generate the ICL signal. The system also repairs ICLs in a reaction that involves extensive, error-free DNA synthesis. Repair occurs by both origin-dependent and origin-independent mechanisms. Our data suggest that cell sensitivity to crosslinking agents results from both checkpoint and DNA repair defects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748363      PMCID: PMC2756577          DOI: 10.1016/j.molcel.2009.08.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  53 in total

1.  The ATPase activity of MCM2-7 is dispensable for pre-RC assembly but is required for DNA unwinding.

Authors:  Carol Y Ying; Jean Gautier
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

2.  The role of BRCA2 in replication-coupled DNA interstrand cross-link repair in vitro.

Authors:  Lubos Cipak; Norifumi Watanabe; Tadayoshi Bessho
Journal:  Nat Struct Mol Biol       Date:  2006-07-16       Impact factor: 15.369

Review 3.  DNA interstrand cross-link repair in the cell cycle: a critical role for polymerase zeta in G1 phase.

Authors:  Peter J McHugh; Sovan Sarkar
Journal:  Cell Cycle       Date:  2006-05-15       Impact factor: 4.534

4.  The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks.

Authors:  Katsuhiro Hanada; Magda Budzowska; Mauro Modesti; Alex Maas; Claire Wyman; Jeroen Essers; Roland Kanaar
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

Review 5.  Formation and repair of interstrand cross-links in DNA.

Authors:  David M Noll; Tracey McGregor Mason; Paul S Miller
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

6.  DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase zeta.

Authors:  Sovan Sarkar; Adelina A Davies; Helle D Ulrich; Peter J McHugh
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

7.  An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.

Authors:  Wenge Zhu; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

8.  Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.

Authors:  Deborah Chirnomas; Toshiyasu Taniguchi; Michelle de la Vega; Ami P Vaidya; Maria Vasserman; Anne-Renee Hartman; Richard Kennedy; Rosemary Foster; Jennifer Mahoney; Michael V Seiden; Alan D D'Andrea
Journal:  Mol Cancer Ther       Date:  2006-04       Impact factor: 6.261

9.  Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks.

Authors:  Alexandra Sobeck; Stacie Stone; Vincenzo Costanzo; Bendert de Graaf; Tanja Reuter; Johan de Winter; Michael Wallisch; Yassmine Akkari; Susan Olson; Weidong Wang; Hans Joenje; Jan L Christian; Patrick J Lupardus; Karlene A Cimprich; Jean Gautier; Maureen E Hoatlin
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

10.  A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.

Authors:  Igor Landais; Alexandra Sobeck; Stacie Stone; Alexis LaChapelle; Maureen E Hoatlin
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

View more
  63 in total

Review 1.  Orchestrating the nucleases involved in DNA interstrand cross-link (ICL) repair.

Authors:  Blanka Sengerová; Anderson T Wang; Peter J McHugh
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 2.  Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.

Authors:  Angelo Guainazzi; Orlando D Schärer
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

Review 3.  Ubiquitin signalling in DNA replication and repair.

Authors:  Helle D Ulrich; Helen Walden
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-16       Impact factor: 94.444

Review 4.  The differences between ICL repair during and outside of S phase.

Authors:  Hannah L Williams; Max E Gottesman; Jean Gautier
Journal:  Trends Biochem Sci       Date:  2013-07-03       Impact factor: 13.807

5.  DNA Damage Response in Xenopus laevis Cell-Free Extracts.

Authors:  Tomas Aparicio Casado; Jean Gautier
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Cell-free Xenopus egg extracts for studying DNA damage response pathways.

Authors:  Steven Cupello; Christine Richardson; Shan Yan
Journal:  Int J Dev Biol       Date:  2016       Impact factor: 2.203

Review 7.  Mechanisms of DNA damage, repair, and mutagenesis.

Authors:  Nimrat Chatterjee; Graham C Walker
Journal:  Environ Mol Mutagen       Date:  2017-05-09       Impact factor: 3.216

Review 8.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

9.  Differential toxicity of DNA adducts of mitomycin C.

Authors:  Jill Bargonetti; Elise Champeil; Maria Tomasz
Journal:  J Nucleic Acids       Date:  2010-07-29

10.  Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.

Authors:  Igor Landais; Sanne Hiddingh; Matthew McCarroll; Chao Yang; Aiming Sun; Mitchell S Turker; James P Snyder; Maureen E Hoatlin
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.